Insights into the MOMENTUM Trial

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

Las 10 de Erazno, el Chokolatazo, Parodias, Nacadas y mas 1h 25m · 22 Sep 2026 · Erazno y La Chokolata El Podcast

Cross-code immorality, Lachie Neale's strike, crowd behaviour - Andrew Voss | Across the Divide! (22.09.26) 17 min · 22 Sep 2026 · Whateley

S13 EP19: It's Exhausting Having an Opinion 37 min · 22 Sep 2026 · Parenting Hell with Rob Beckett and Josh Widdicombe

Fall in Love With the Life You Have 51 min · 22 Sep 2026 · The Candace Cameron Bure Podcast

NPR News: 09-21-2026 9PM EDT 5 min · 22 Sep 2026 · NPR News Now

Report any issue

Source

Recorded30 Mar 2023

Publisherfeeds.buzzsprout.com

Handlerec:1648236

Show notes

Aaron Gerds, MD, MS, a hematologist in Cleveland Clinic Cancer Center’s Leukemia and Myeloid Disorders Program and Deputy Director for Clinical Research at the Taussig Cancer Institute joins the Cancer Advances podcast to talk about the MOMENTUM trial that was presented at the American Society of Hematology (ASH) 2022 annual meeting. Listen as Dr. Gerds discusses myelofibrosis, the differences between the trial results from 24 to 48 weeks, and the exciting new approaches that are coming to the field.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in